These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

223 related items for PubMed ID: 27304650

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. -643C > T RANKL gene polymorphism is associated with osteoporosis in Tunisian postmenopausal women.
    Sassi R, Sahli H, Cheour E, Sellami S, El Gaaied ABA.
    Climacteric; 2017 Aug; 20(4):374-378. PubMed ID: 28453307
    [Abstract] [Full Text] [Related]

  • 4. Association between osteoprotegerin (OPG), receptor activator of nuclear factor-kappaB (RANK), and RANK ligand (RANKL) gene polymorphisms and circulating OPG, soluble RANKL levels, and bone mineral density in Korean postmenopausal women.
    Kim JG, Kim JH, Kim JY, Ku SY, Jee BC, Suh CS, Kim SH, Choi YM.
    Menopause; 2007 Aug; 14(5):913-8. PubMed ID: 17667143
    [Abstract] [Full Text] [Related]

  • 5. OPG, RANKL, and RANK gene polymorphisms and the bone mineral density response to alendronate therapy in postmenopausal Chinese women with osteoporosis or osteopenia.
    Zheng H, Wang C, He JW, Fu WZ, Zhang ZL.
    Pharmacogenet Genomics; 2016 Jan; 26(1):12-9. PubMed ID: 26426211
    [Abstract] [Full Text] [Related]

  • 6. [Polymorphism of osteoprotegerin gene and osteoporosis in postmenopausal women].
    Seremak-Mrozikiewicz A, Tatuśko J, Drews K, Barlik M, Krajewski P, Spaczyński M, Mrozikiewicz PM.
    Ginekol Pol; 2009 May; 80(5):354-60. PubMed ID: 19548455
    [Abstract] [Full Text] [Related]

  • 7. Raloxifene pharmacodynamics is influenced by genetic variants in the RANKL/RANK/OPG system and in the Wnt signaling pathway.
    Mencej-Bedrač S, Zupan J, Mlakar SJ, Zavratnik A, Preželj J, Marc J.
    Drug Metabol Drug Interact; 2014 May; 29(2):111-4. PubMed ID: 24615483
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The influence of Lys3Asn polymorphism in the osteoprotegerin gene on bone mineral density in Chinese postmenopausal women.
    Zhao HY, Liu JM, Ning G, Zhao YJ, Zhang LZ, Sun LH, Xu MY, Uitterlinden AG, Chen JL.
    Osteoporos Int; 2005 Dec; 16(12):1519-24. PubMed ID: 15782282
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Gene-gene interactions in RANK/RANKL/OPG system influence bone mineral density in postmenopausal women.
    Zupan J, Mencej-Bedrac S, Jurković-Mlakar S, Prezelj J, Marc J.
    J Steroid Biochem Mol Biol; 2010 Jan; 118(1-2):102-6. PubMed ID: 19896533
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Genetic variation in the RANKL/RANK/OPG signaling pathway is associated with bone turnover and bone mineral density in men.
    Roshandel D, Holliday KL, Pye SR, Boonen S, Borghs H, Vanderschueren D, Huhtaniemi IT, Adams JE, Ward KA, Bartfai G, Casanueva F, Finn JD, Forti G, Giwercman A, Han TS, Kula K, Lean ME, Pendleton N, Punab M, Silman AJ, Wu FC, Thomson W, O'Neill TW, EMAS Study Group.
    J Bone Miner Res; 2010 Aug; 25(8):1830-8. PubMed ID: 20205168
    [Abstract] [Full Text] [Related]

  • 15. Association of TNFSF11 gene promoter polymorphisms with bone mineral density in postmenopausal women.
    Mencej S, Prezelj J, Kocijancic A, Ostanek B, Marc J.
    Maturitas; 2006 Oct 20; 55(3):219-26. PubMed ID: 16730419
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. RANKL and OPG gene polymorphisms: associations with vertebral fractures and bone mineral density in premenopausal systemic lupus erythematosus.
    Bonfá AC, Seguro LP, Caparbo V, Bonfá E, Pereira RM.
    Osteoporos Int; 2015 May 20; 26(5):1563-71. PubMed ID: 25609157
    [Abstract] [Full Text] [Related]

  • 18. Relationships among serum receptor of nuclear factor-kappaB ligand, osteoprotegerin, high-sensitivity C-reactive protein, and bone mineral density in postmenopausal women: osteoimmunity versus osteoinflammatory.
    Nabipour I, Larijani B, Vahdat K, Assadi M, Jafari SM, Ahmadi E, Movahed A, Moradhaseli F, Sanjdideh Z, Obeidi N, Amiri Z.
    Menopause; 2009 May 20; 16(5):950-5. PubMed ID: 19387415
    [Abstract] [Full Text] [Related]

  • 19. Genetic profiling of decreased bone mineral density in an independent sample of Caucasian women.
    Xiao X, Roohani D, Wu Q.
    Osteoporos Int; 2018 Aug 20; 29(8):1807-1814. PubMed ID: 29713799
    [Abstract] [Full Text] [Related]

  • 20. Higher levels of s-RANKL and osteoprotegerin in children and adolescents with type 1 diabetes mellitus may indicate increased osteoclast signaling and predisposition to lower bone mass: a multivariate cross-sectional analysis.
    Tsentidis C, Gourgiotis D, Kossiva L, Doulgeraki A, Marmarinos A, Galli-Tsinopoulou A, Karavanaki K.
    Osteoporos Int; 2016 Apr 20; 27(4):1631-1643. PubMed ID: 26588909
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.